Congress Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
YIH
BPC
FFM
BPCE
Congress Asset Management's BSX Position: Q2 2026 in Review
Congress Asset Management reduced its Boston Scientific (BSX) stake by 99% in Q2 2026, selling an estimated $87.9M and leaving 10,247 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #337.
Congress Asset Management first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $183M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Congress Asset Management held 10,247 shares of Boston Scientific worth $437K as of Q2 2026.
- Congress Asset Management sold 1,619,238 Boston Scientific shares in Q2 2026, an estimated $87.9M.
- Boston Scientific made up ﹤0.01% of Congress Asset Management's portfolio in Q2 2026, its #337 holding.
- Congress Asset Management first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
- Congress Asset Management's Boston Scientific position peaked at $183M in Q2 2025.
- 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.